Balanced news tone
News Sentiment
PYPD sentiment intelligence
PolyPid news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+4.2% over one week, +13.2% over four weeks, trend active, and near fair-value range.
PolyPid Ltd. (PYPD) boosts option pool by 1.5M shares and clears CEO grant
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
New surgical infection drug from PolyPid heads to FDA decision in 2027
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 12:30
- Source
- GlobeNewswire
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
PolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 23:01
- Source
- GuruFocus.com
PolyPid Ltd. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 20:58
- Source
- Moby
PolyPid (PYPD) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 19:01
- Source
- Motley Fool
PolyPid Q1 2026 Earnings Call: Complete Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 13:24
- Source
- Benzinga
Earnings call transcript: PolyPid’s Q1 2026 earnings beat expectations, stock rises
- Tone
- Positive 84/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Investing.com
PolyPid Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- TradingView
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- GlobeNewswire
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- GlobeNewswire
Aurum holds 5,001,561 shares in Polypid Ltd. (PYPD) with exercisable warrants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Feb 2026 08:00
- Source
- Market source
Is PolyPid (NASDAQ:PYPD) A Risky Investment?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Oct 2025 07:00
- Source
- simplywall.st
Wall Street Analyst Says PolyPid is a Buy with 300% Potential Upside as it nears Phase 3 Data Readout
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 02 Jun 2025 07:00
- Source
- newsblaze.com
PolyPid (PYPD) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2020 12:59
- Source
- MarketBeat